Skip to main content
Clinical Trials/DRKS00011133
DRKS00011133
Completed
Phase 4

Impact of right heart function and pulmonary venous Hypertension on CRT Response in patients with left ventricular dysfunction and dyssynchrony - Bivent

niversitätsklinikum Magdeburg0 sites115 target enrollmentJanuary 30, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
I50
Sponsor
niversitätsklinikum Magdeburg
Enrollment
115
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 30, 2017
End Date
December 7, 2012
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Magdeburg

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with heart failure symptoms lasting at least 6 weeks (according to the
  • current guidelines for CRT treatment of chronic heart failure)
  • 2\. At least 18 years of age
  • 3\. Medical need for implants (implants based on the standard implant guidelines
  • from the European Society of Cardiology (ESC))
  • 4\. Left ventricular ejection fraction (LVEF) \< 35% as assessed by the investigator
  • 5\. NYHA functional status II, III or IV
  • 6\. QRS duration \> 130 ms
  • 7\. Medical therapy, unless contraindicated, includes
  • \- ACE inhibitor or

Exclusion Criteria

  • 1\. Life expectancy \< 12 months
  • 2\. Pregnancy (routine test before left and right heart catheter examination)
  • 3\. Prior CRT
  • 4\. Atrial arrhythmias
  • 5\. Right bundle branch block
  • 6\. QRS \< 130 ms
  • 7\. Heart failure requiring continuous intravenous therapy
  • 8\. Patients with acute coronary syndromes or coronary revascularization within 4
  • months before CRT

Outcomes

Primary Outcomes

Not specified

Similar Trials